Bone growth stimulators. New tools for treating bone loss and mending fractures

Vitamins and hormones

Volumn 65, Issue , 2002, Pages 1-80

  Whitfield, James F ^a   Morley, Paul ^b   Willick, Gordon E ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b ParaTecH Therapeutics Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH PROMOTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE;

ANIMAL; BONE; BONE DEVELOPMENT; BONE REMODELING; FEMALE; FRACTURE; HUMAN; INJURY; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE REMODELING; ESTROGENS; FEMALE; FRACTURES, BONE; GROWTH SUBSTANCES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; OSTEOGENESIS; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE;

EID: 0036044205     PISSN: 00836729     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0083-6729(02)65059-9     Document Type: Review

References (474)

1. M.M. Aarts A. Rix J. Guo The nucleolar targeting signal (NTS) of parathyroid hormone-related protein mediates endocytosis and nucleolar translocation J. Bone Miner. Res. 14 1999 1493 1503
2. C. Adams K. Mansfield R.L. Perlot Matrix regulation of skeletal cell apoptosis: Role of calcium and phosphate atoms J. Biol. Chem. 276 2001 20316 20322
3. J. Aguirre L. Buttery M. O'Shaughnessy Endothelial nitric oxide synthase genedeficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity Am. J. Pathol. 158 2001 247 257
4. R.S. Ahima J.S. Flier Leptin Annu. Rev. Physiol. 62 2000 413 437
5. F. Amalric V. Baldin I. Bosc-Bierne Nuclear translocation of basic fibroblastic growth factor Ann. N.Y. Acad. Sci. 638 1991 127 138
6. D. Amin S.A. Cornell S.K. Gustafson Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis J. Lipid Res. 33 1992 1657 1663
7. N. Amizuka A.C. Karaplis J.E. Henderson Haploinsufficiency of parathyroid hormone related peptide (PTHrP) results in abnormal postnatal development Dev. Biol. 175 1996 166 176
8. M. Amling L. Neff S. Tanaka Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development J. Cell Biol. 136 1997 205 213
9. R.G.W. Anderson The caveolar membrane system Annu. Rev. Biochem. 67 1998 199 225
10. T.T. Andreassen H. Oxlund The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats J. Bone Miner. Res. 15 2000 2266 2275
11. T.T. Andreassen C. Ejersted H. Oxlund Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures J. Bone Miner. Res. 14 1999 960 968
12. T.T. Andeassen G.E. Willick P. Morley Treatment with parathyroid hormone fragments increases fracture strength and enhances callus amount—Strength and callus amount normalize after treatment withdrawal (abstract) J. Bone Miner. Res. 16 2001 S425
13. B. Antonsson J.C. Martinou The Bcl-2 protein family Exp. Cell Res. 256 2000 50 57
14. K.E. Armour K.J. Armour M.E. Gallagher Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase Endocrinology 142 2001 760 766
15. M.C. Ashby A.V. Tepikin ER calcium and the functions of intracellular organelles Cell Dev. Biol. 12 2001 11 17
16. J.E. Aubin Advances in the osteoblast lineage Biochem. Cell Biol. 76 1998 899 910
17. J.E. Aubin The role of osteoblasts J.E. Henderson D. Goltzman The Osteoporosis Primer 2000 Cambridge University Press Cambridge 18 35
18. J.E. Aubin Regulation of osteoblast formation and function Rev. Endocrine Metab. Dis. 2 2001 81 94
19. J.E. Aubin E. Bonnelye Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption Medscape Women's Health 5 2000 http://www.medscape.com
20. J.E. Aubin J.E. Triffitt Mesenchymal stem cells and osteoblast differentiation 2nd Principles of Bone Biology Vol. 1 2002 Academic Press San Diego 59 91
21. J. Bandorowicz-Pikula R. Bucher S. Pikula Annexins as nucleotide-binding proteins: Facts and speculations BioEssays 23 2001 170 178
22. C. Banerjee A. Javed J.Y. Choi Differential regulation of the two principal Runx2/Cbfal n-terminal isoforms in response to protein morphogenic protein-2 during development of the osteoblast phenoptype Endocrinology 142 2001 4026 4039
23. J.-R. Barbier W. Neugebauer P. Morley Bioactivities and secondary structures of constrained analogues of human parathyroid hormone: Cyclic lactams of the receptor-binding region J. Med. Chem. 40 1997 1373 1380
24. F. Barsilana M. Susa H.J. Keller Human mesenchymal cells undergoing osteogenic differentiation express leptin and and functional leptin receptors (abstract) J. Bone Miner. Res. 15 2000 S378
25. D.C. Bauer G.R. Mundy S.A. Jamal Satatin use, bone mass and fracture: An analysis of two prospective studies (abstract) J. Bone Miner. Res. 14 1999 S179
26. E. Bauer J.C. Aub F. Albright Studies of calcium and phosphorus metabolism: V. Study of the bone trabeculae as a readily available reserve supply of calcium J. Exp. Med. 49 1929 145 162
27. D.J. Baylink D.D. Strong S. Mohan The diagnosis and treatment of osteoporosis: Future prospects Mol. Med. Today 5 1999 133 140
28. G.R. Beck Jr. B. Zerler E. Moran Phosphate is a specific signal for induction of osteopontin gene expression Proc. Natl. Acad. Sci. USA 97 2000 8352 8357
29. P.J. Bekker D. Holloway A. Nakanishi The effect of a single dose of osteoprotegerin in postmenopausal women J. Bone Miner. Res. 16 2001 348 360
30. T. Bellido L.I. Plotkin J. Davis Protein kinase A-dependent phosphorylation and inactivation of the pro-apoptotic protein Bad mediates the anti-apoptotic effect of PTH on osteoblastic cells (abstract) J. Bone Miner Res. 16 2001 S203
31. H.L. Benford J.C. Frith S. Auriola Famesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs Mol. Pharmacol. 56 2001 131 140
32. H.L. Benford N.W. McGowan M.H. Helfrich Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro Bone 28 2001 465 473
33. W.P. Benten C. Stephan M. Lieberherr Estradiol signaling via sequestrable surface receptors Endocrinology 142 2001 1669 1677
34. P. Bianco M. Riminucci The bone marrow stroma in vivo : Ontogeny, structure, cellular composition and changes in disease J.N. Beresford M.E. Owen Marrow Stromal Cell Culture 1998 Cambridge University Press Cambridge 10 25
35. P. Bianco J.N. Bradbeer M. Riminucci Marrow stromal cells: Identification, morphometry, confocal imaging and changes in disease Bone 14 1993 315 320
36. P. Bianco M. Riminucci S. Kuznetsov Multipotential cells in the bone marrow stroma: Regulation in the context of organ physiology Crit. Rev. Euk. Gene Express. 10 1999 159 173
37. D.D. Bikle J. Harris B.P. Halloran Skeletal unloading induces resistance to insulin-like growth factor J. Bone Miner. Res. 9 1994 1789 1796
38. J. Bockaert S. Claeysen C. Bϑcamel G protein-coupled receptors: dominant players in cell-cell communication Int. Rev. Cytol. 212 2002 63 132
39. G.Y. Boivin P.M. Chavassieux A.C. Santors Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women Bone 27 2000 687 694
40. J. Bonadio Tissue engineering via local gene delivery: Update and future prospects for enhancing the technology Adv. Drug Del. Rev. 44 2000 185 194
41. J. Bonadio E. Smiley P. Path Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration Nat. Med. 5 1999 753 759
42. M.L. Bouxsein Etiology and biomechanics of hip and vertebral fractures R. Marcus Atlas of Clinical Endocrinology, Vol. 3, Osteoporosis 1999 Current Medicine Philadelphia 139 148
43. W.H. Bowler K.A. Buckley A. Gartland Extracellular nucleotide signaling: A mechanism for integrating local and systemic responses in the activation of bone remodeling Bone 28 2001 507 512
44. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone J. Bone Miner. Res. 11 1996 600 613
45. M.L. Brandi C. Crescioli A. Tanini Bone endothelial cells as estrogen targets Calcif. Tissue Int. 53 1993 312 317
46. D.W. Brann L. De Sevilla P.L. Zamorano Regulation of leptin gene expression and secretion by steroid hormones Steroids 64 1999 659 663
47. R. Brommage C.E. Hotchkiss C.J. Lees Daily treatment with human recombinant parathyroid hormone-(1–34), LY33333, for 1 year increases bone mass in ovariectomized monkeys J. Clin. Endocrinol. Metab. 84 1999 3757 3763
48. E.M. Brown R.J. MacLeod Extracellular calcium sensing and extracellular calcium signaling Physiol. Rev. 81 2001 240 297
49. B. Burguera L.C. Hofbauer T. Thomas Leptin reduces ovariectomy-induced bone loss in rats Endocrinology 2001 3546 3553 142
50. D.B. Burr T. Hirano C.H. Turner Intermittently administered human parathyroid hormone (1–34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomize cynomolgus monkeys J. Bone Miner. Res. 16 2001 157 165
51. L.M. Calvi N.A. Sims J.L. Hunzelman Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone J. Clin. Invest. 107 2001 277 286
52. G.A. Candeliere F. Liu J.E. Aubin Individual osteoblasts in the developing calvaria express different gene repertoires Bone 28 2001 351 361
53. C.E. Cann E.B. Roe S.D. Sanchez PTH effects in the femur: Envelope-specific responses by 3DQCT in postmenopausal women (abstract) J. Bone. Miner. Res. 14 1999 S137
54. C. Capparelli S. Morony K.S. Warmington Pharmacological effects of a single treatment with osteoprotegerin (OPG) on bone remodeling and bone density in normal rats (abstract) J. Bone Miner. Res. 15 2000 S171
55. J. Caverzasio J.R. Bonjour Characteristics and regulation of Pi transport in osteogenic cells for bone metabolism Kidney Int. 49 1996 975 980
56. S. Cenci M.N. Weitzmann C.R. Roggia Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α J. Clin. Invest. 106 2000 1229 1237
57. K.L. Chambliss I.S. Yuhanna C. Mineo Estrogen receptor alpha and endothelial nitric oxide synthase are organized into functional signaling module in caveolae Circ. Res. 87 2000 E44 E52
58. K. Chan S.E. Andrade M. Boles Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women Lancet 355 2000 2185 2188
59. M.H. Chan T.W. Mak R.W. Chiu Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia J. Clin. Endocrinol. Metab. 86 2001 4556 4559
60. 2+ regulates fluid shear-induced cyto-skeletal reorganization and gene expression in osteoblasts Am. J. Physiol. Cell Physiol. 278 2000 C989 C997
61. D.J. Chang C. Ji K.K. Kim Reduction in transforming growth factor beta receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid J. Biol. Chem. 273 1998 4892 4896
62. W. Chang C. Tu T.H. Chen Expression and signal transduction of calcium-sensing receptors in cartilage and bone Endocrinology 140 1999 5883 5893
63. D.T. Chao S.J. Korsmeyer BCL-2 family: Regulators of cell death Annu. Rev. Immunol 16 1998 395 419
64. S. Chauvin J. Vilardaga M. Benecsik Parathyroid hormone receptor recycling: Regulation by specific structural features of the receptor (abstract) J. Bone Miner. Res. 16 2001 S228
65. C. Chen D.N. Kalu Modulation of intestinal estrogen receptor by ovariectomy, estrogen and growth hormone J. Pharmacol. Exp. Ther. 286 1998 328 333
66. D. Chen X. Ji M.A. Harris Differential roles for bone morphogenic protein (BMP) receptor type 113 and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages J. Cell Biol. 142 1998 295 305
67. D. Chen I.R. Garrett M. Qiao Proteasome inhibitors stimulate osteoblast differentiation and bone formation by inhibiting GL13 degradation and enhancing BMP-2 expression (abstract) Bone 28 2001 S74
68. J.W. Chow S. Fox C.J. Jagger Role of parathyroid hormone in mechanical responsiveness of bone Am. J. Physiol. 274 1998 E146 E154
69. S.-C. Chu Y.-C. Chou J.-Y. Liu Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement Life Sci. 64 1999 2299 2306
70. U. Chung E. Schipani A.P. McMahon Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development J. Clin. Invest. 107 2001 295 304
71. Y.S. Chung M.D. Lee S.K. Lee HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients J. Clin. Endocrinol. Metab. 85 2000 1137 1142
72. J.A. Cole Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells Endocrinology 140 1999 5771 5779
73. D. Coppock C. Kopman J. Gudas Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29 Biochem. Biophys. Res. Commun. 269 2000 604 610
74. J. Cornish K.E. Callon G.C. Nicholson Parathyroid hormone-related protein(107–139) inhibits bone resorption in vivo Endocrinology 138 1997 1299 1304
75. J. Cornish K.E. Callon C. Lin Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein J. Bone Miner. Res. 14 1999 915 922
76. J. Cornish K.E. Callon U. Bava The direct actions of leptin on bone cells increase bone strength in vivo : An explanation of low fracture rates in obesity (abstract) Bone 28 2001 S88
77. F. cosman R. Lindsay Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence Calcif. Tissue Int. 62 1998 475 480
78. F. Cosman R. Lindsay Parathyroid hormone as an anabolic treatment J.C. Stevenson R. Lindsay Osteoporosis 1998 Chapman & Hall London 293 307
79. F. Cosman J. Nieves L. Woelfert Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women J. Bone. Miner. Res. 13 1998 1051 1055
80. F. Cosman J. Nieves L. Formica Parathyroid hormone in combination with estrogen dramatically reduces vertebral fracture risk (abstract) Osteoporosis Int. 11 Suppl. 2 2000 S176
81. F. Cosman J. Nieves L. Woelfert Parathyroid hormone added to established hormone therapy: Effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal J. Bone Miner. Res. 16 2001 925 931
82. F. Cosman J. Nieves M. Zion Effects of short-term cerivastatin on bone turnover (abstract) J. Bone Miner. Res. 16 2001 S296
83. D.T. Crawford H. Qi K.L. Chisey-Frink Stalin increases cortical bone in young male rats by single, local administration but fails to restore bone to ovariectomized (OVX) rats by daily systemic administration (abstract) J. Bone Miner. Res. 16 2001 S295
84. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem. J. 341 2000 233 249
85. R.M. Cuthbertson B.E. Kemp J.A. Barden Structure of osteostatin PTHrP[Thr 107] (107–139) Biochim. Biophys. Acta 1432 1999 64 72
86. A.G. Daifotis E.C. Weir B.E. Dreyer Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus J. Biol. Chem. 267 1992 23455 23458
87. H. Daub C. Wallasch A. Lankenau Signal characteristics of G protein-transactivated EGF receptor EMBO J. 16 1997 7032 7044
88. +-ATPase J. Bone Miner. Res. 11 1996 1498 1507
89. P.D. Delmas P. Vergnaud M.E. Arlot The anabolic effect of human PTH (1–34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate—Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16 1995 603 610
90. D.W. Dempster Bone remodeling B.L. Riggs L.J. Melton III Osteoporosis: Etiology, Diagnosis, and Management 2nd ed. 1995 Lippincott-Raven Philadelphia 67 91
91. D.W. Dempster Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis J. Bone Miner. Res. 12 1997 1152 1154
92. D.W. Dempster The contribution of trabecular architecture to cancellous bone quality J. Bone Miner. Res. 15 2000 20 23
93. D.W. Dempster F. Cosman M. Parisien Anabolic action of parathyroid hormone Endocrine Rev. 14 1993 690 709
94. D.T. Denhardt M. Noda Osteopontin expression and function: Role in bone remodeling J. Cell. Biochem. Suppl. 30–31 1998 92 102
95. V. DiMarzo S.K. Goparaju L. Wang Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 12 2001 822 825
96. P. Divieti N. Inomata K. Chapin Receptors for the carboxyl-terminal region of PTH(1–84) are highly expressed in ostocytic cells Endocrinology 142 2001 916 925
97. H. Dobnig R.T. Turner Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells Endocrinology 136 1995 3632 3638
98. H. Dobnig R.T. Turner The effects of programmed administration of human parathyroid hormone fragment (1–34) on bone histomorphometry and serum chemistry in rats Endocrinology 138 1997 4607 4612
99. K.B. Dobson T.M. Skerry The NMDA-type glutamate receptor antagonist MK801 regulates the differentiation of rat bone marrow osteoprogenitors and influence adipogenesis (abstract) J. Bone Miner. Res. 15 2000 S272
100. M. Dodig T. Tadic M.S. Kronenberg Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation Dev. Biol. 209 1999 298 307
101. M.J. Doherty A.E. Canfield Gene expression during vascular pericyte differentiation Crit. Rev. Euk. Gene Express. 9 1999 1 17
102. I by 17β-oestradiol in female rat distal colon Br. J. Pharmacol. 129 2000 1375 1386
103. P. Ducy Cbfa1: A molecular switch in osteoblast biology Dev. Dynam. 219 2000 461 471
104. P. Ducy M. Amling S. Takeda Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass Cell 100 2000 197 207
105. P. Ducy T. Schinke G. Karsenty The osteoblast: A sophisticated fibroblast under central surveillance Science 289 2000 501 1504
106. 2+-conducting channels in an osteoblast-like cell line (UMR 106) FEBS Lett. 251 1989 17 21
107. R.L. Duncan K.A. Hruska S. Misler Parathyroid hormone activation of stretch-activated cation channels in osteosarcoma cells (UMR 106.01) FEBS Lett. 307 1992 219 223
108. M. Edlich C.E. Yellowley C.R. Jacobs Oscillating fluid flow regulates cytosolic calcium concentration in bovine articular chondrocytes J. Biomech. 34 2001 59 65
109. C.J. Edwards D.J. Hart T.D. Spector Oral status and increased bone mineral density in postmenopausal women Lancet 355 2000 2218 2219
110. T.A. Einhorn Biomechanics of bone J.P. Bilzekian L.G. Raisz G.A. Rodan Principles of Bone Biology 1996 Academic Press San Diego 25 37
111. A. Enjuanes A. Supervia X. Noguϑs Leptin receptor (OB-R) gene expression in human primary osteoblasts : confirmation J. Bone Miner. Res. 17 2002 1135
112. E.F. Eriksen D.W. Axelrod F. Melsen Bone Histomorphometry 1994 Raven Press New York
113. E.F. Eriksen B. Langdahl M. Klassen The cellular basis of osteoporosis Spine: State Arts Rev. 8 1994 23 62
114. P. Esbrit M.V. Alvarez-Arroyo F. De Miguel C-terminal parathyroid hormone-related protein increases vascular endothelial growth factor in human osteoblastic cells J. Am. Soc. Nephrol. 11 2000 1085 1092
115. L. Espinosa C. Itzstein H. Cheynel Active NMDA glutamate receptors are expressed by mammalian osteoclasts J. Physiol. 518 1999 47 53
116. B.A.J. Evans C. Elford J.W. Gregaory Leptin control of bone metabolism (abstract) Bone 28 2001 S149
117. V. Everts J.M. Delaissϑ W. Korper D. Jansen W. Tigchelaar-Gutter P. Saftig W. Beertsen The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation J. Bone Miner. Res. 17 2002 77 90
118. B. Fadeel B. Zhivotovsky S. Orrenius All along the watchtower: On the regulation of apoptosis regulators FASEB J. 13 1999 1647 1657
119. E. Falkenstein H.-C. Tillmann M. Christ Multiple actions of steroid hormones—a focus on rapid, nongenomic effects Pharmacol Rev. 52 2000 513 555
120. J. Fang Y.Y. Zhu E. Smiley Stimulation of new bone formation by direct transfer of osteogenic plasmid genes Proc. Natl. Acad. Sci. USA 93 1996 5753 5758
121. M.Y. Farhat M.C. Lavigne P.W. Ramwell The vascular protective effects of estrogen FASEB J. 10 1996 615 624
122. J.R. Farley B. Stilt-Coffing Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells Calcif Tissue Int. 2001 published online 23 February
123. A. Farzaneh-Far D. Proudfoot P.L. Weisberg Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor Biochem. Biophys. Res. Commun. 277 2000 736 740
124. K. Fassbender M. Simons C. Bergmann Simvaststin strongly reduces levels of Alzheimer's disease β amyloid peptides Aβ42 and Aβ40 in vivo and in vitro Proc. Natl. Acad. Sci. USA 98 2001 5856 5861
125. K. Faulkner Bone matters: Are density increases necessary to reduce fracture risk? J. Bone Miner Res. 15 2000 183 187
126. A.J. Fenton B.E. Kemp R.G. Hammonds A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107–111] Endocrinology 129 1991 3424 3426
127. B. Fermore T.M. Skerry PTH/PTHrP receptor expression in osteoblasts and osteocytes but not resorbing bone surfaces in growing rats J. Bone Miner. Res. 10 1995 1935 1943
128. O. Feron C. Dessy J.-P. Desager Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance Circulation 103 2001 113 118
129. C.J. Fielding P.E. Fielding Caveolae and intracellular trafficking of cholesterol Adv. Drug Del. Rev. 49 2001 251 264
130. E. Finkel The mitochondrion: Is it central to apoptosis? Science 292 2001 624 626
131. G. Fiorelli F. Gori U. Frediani Membrane-binding sites and non-genomic effects of estrogen in cultured human preosteoclastic cells J. Steroid Biochem. Mol. Biol. 59 1996 233 240
132. J.E. Fisher M.J. Rogers J.M. Halasay Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro Proc. Natl. Acad. Sci. USA 96 1999 133 138
133. J.C. Fleet Leptin and bone: Does the brain control bone biology? Nutr Rev. 58 2000 209 211
134. H. Fleisch Bisphosphonates in Bone Disease 1997 The Parthenon Publishing Group London
135. H. Fleisch Bisphosphonates: Mechanisms of action Endocrine Rev. 19 1998 80 100
136. L.J. Fraher R. Avram P.H. Watson A comparison of the biochemical responses to 1–31 hPTH and 1–34 hPTH given to healthy humans by slow infusion J. Clin. Endocrinol. Metab. 84 1999 2739 2743
137. R.T. Franceschi The developmental control of osteoblast-specific gene expression: Role of specific transcription factors and the extracellular matrix environment Crit. Rev. Oral Biol. Med. 10 1999 40 57
138. J.M. Friedman Obesity in the new millennium Nature 404 2000 632 634
139. P.A. Friedman F.A. Gesek P. Morley Cell-specific signaling and structure-activity relations of parathyroid analogs in mouse kidney cells Endocrinology 140 1999 301 309
140. S.M. Frisch R.A. Screaton Anoikis mechanisms Curr. Opin. Cell Biol. 13 2001 555 562
141. H.M. Frost Osteoporoses J.F. Whitfield P. Morley Anabolic Treatments for Osteoporosis 1997 CRC Press Boca Raton, FL 1 27
142. Q. Fu R.L. Jilka S.C. Manolagas Stimulation of RANKL gene transcription and mRNA stability in stroma/osteoblastic cells by PTH: A direct effect mediated by the protein kinase pathway (abstract) J. Bone Miner. Res. 16 2001 S485
143. A. Fujimori S.L. Cheng L.V. Avioli Structure-function relationship of parathyroid hormone: Activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells Endocrinology 130 1992 29 36
144. T. Fujita T. Inoue H. Morii Effect of an intermittent weekly dose of human parathyroid hormone (1–34) on osteoporosis: A randomized double-masked prospective study using three dose levels Osteoporosis Int. 9 1999 296 306
145. T. Fujita R. Fukuyama N. Izumo Enhanced Cbfal transactivation as a basic mechanism to trigger bone anabolic action of PTH(1–34) (abstract) J. Bone Miner. Res. 15 2000 S373
146. T. Fujita R. Fukuyama N. Izumo Transactivation of of core binding factor αl as a basic mechanism to trigger parathyroid hormone-induced osteogenesis Jpn. J. Pharmacol 86 2001 405 416
147. T. Fujita N. Izumo R. Fukuyama Phosphate provides an extracelluar signal that drives nuclear export of Runx2/Cbfa1 in bone cells Biochem. Biophys. Res. Commun. 280 2001 348 352
148. S. Fukumoto Localization and function of calcium-sensing receptors in bone cells Nippon Rinsho 56 1998 1419 1424
149. O. Gallien-Lartigue D. Carrez Induction in vitro de la phase S dans les cellules couches multipotentes de la moelle osseuse par l'hormone parathroidienne C. R. Acad. Sci. Paris [D] 278 1974 1765 1768
150. R.J.S. Galvin T.R. Fuson X. Yang hPTH (1–38) stimulation of bone resorption in murine calvariae is mediated in part by its ability to decrease OPG (abstract) J. Bone Miner. Res. 16 2001 S449
151. I.R. Garrett G. Gutierrez D. Chen Specific inhibitors of the chymotryptic component of the proteasome are potent bone anabolic agents (abstract) J. Bone Miner. Res. 15 2000 S197
152. I.R. Garrett D. Chen M. Zhao Statins mediate bone formation by enhancing BMP-2 expression (abstract) Bone 28 2001 S75
153. I.R. Garrett G. Gutierrez D. Chen Statins stimulate bone formation by enhancing eNOS expression (abstract) J. Bone Miner. Res. 16 2001 S75
154. I.R. Garrett G. Gutierrez G.R. Mundy Statins and bone formation Curr. Pharm. Design 7 2001 715 736
155. J.A. Gasser Quantitative assessment of bone mass and geometry by pQCT in rats in vivo and site specificity of changes at different skeletal sites J. Jpn. Soc. Bone Morphom. 7 1997 107 114
156. J.A. Gasser Fluvastatin and cerivastatin are notanabolic for bone after local or systemic administration of non-toxic doses in mice and rats (abstract) J. Bone. Miner. Res. 16 2001 S295
157. H.K. Genant C.E. Cann B. Etting Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy Ann. Intern. Med. 97 1982 699 705
158. N. Ghosh-Choudhury J.J. Windle B.A. Koop Immortalized murine osteoblasts derived from BMP2-T antigen expressing transgenic mice Endocrinology 137 1996 331 339
159. A. Gohel G. Gronowicz Glucocorticoids induce apoptosis in osteoblasts in mice by the regulation of BCL-2 and other cell cycle factors (abstract) J. Bone Miner. Res. 12 1997 S284
160. S.A. Goldstein J. Bonadio Potential role for direct gene transfer in the enhancement of fracture healing Clin. Orthop. 355 1998 S154 S162 (Suppl.)
161. D. Goltzman J.H. White Developmental and tissue-specific regulation of parathyroid hormone (PTH)/PTH-related peptide receptor gene expression Crit. Rev. Euk. Gene Express. 10 2000 135 149
162. F. Gori L.C. Hofbauer C.R. dunstan The expression of osteoprotegerin and RANKL ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated Endocrinology 141 2000 4768 4776
163. M. Gowen G.B. Stroup R.A. Dodds Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats J. Clin. Invest. 105 2000 1595 1604
164. C. Gray H. Marie M. Arora Glutamate does not play a major role in controlling bone growth J. Bone Miner. Res. 16 2001 742 749
165. E.M. Greenfield ODF/OPGL is increased by IL-1 and IL-6 (abstract) J. Bone Miner Res. 14 1999 S361
166. Y. Gu S.J. Publicover Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts J. Biol. Chem. 275 2000 34252 34259
167. D. Guaradvaccaro G. Corrente F. Covone Arrest of G1-S progression is Rb dependent and relies on the inhibition of of cyclin D1 transcription Mol. Cell. Biol. 20 2000 1797 1815
168. J.G. Gurney R.K. Severson S. Davis Incidence of cancer in children in the United States. Sex-, race- and 1-year age-specific rates by histologic type Cancer 75 1995 2186 2195
169. G. Gutierrez J.R. Garrett G. Rossini Dermal application of lovaststin to rats causes greater increases in bone formation and plasma concentration than when administered by oral gavage (abstract) J. Bone Miner. Res. 15 2000 S427
170. H. Hagino T. Okano M. Enokida The effect of parathyroid hormone on cortical bone response to in vivo external loading (abstract) J. Bone Miner. Res. 15 2000 806
171. B.Z. Harris W.A. Lim Mechanism and role of PDZ domains in signaling complex assembly J. Cell Sci. 114 2001 3219 3231
172. E.M. Hauge D. Qvesel E.F. Eriksen Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblast markers J. Bone Miner. Res. 16 2001 1575 1582
173. 3 receptor J. Bioenerg. Biomembr. 32 2000 15 25
174. + exchanger regulatory factor family of PDZ proteins Proc. Natl. Acad. Sci. USA 95 1998 8496 8501
175. D.M. Herrington K.P. Klein Statins, hormones, and women: Benefits and drawbacks for athersclerosis and osteoporosis Curr. Atherosclerosis Rep. 3 2001 35 42
176. A. Hershko A. ciechanover A. Varshavsky The ubiquitin system Nat. Med. 6 2000 1073 1081
177. R.D. Hesch U. Busch M. Prokop Increase of vertebral density by combination therapy with pulsatile 1–38 PTH and sequential addition of calcitonin nasal spray in osteoporotic patients Calcif. Tissue Int. 44 1989 176 180
178. P.A. Hill A. Tumber M.C. Meikle Multiple extracellular signals promote osteoblast survival and apoptosis Endocrinology 138 1997 3849 3858
179. T.K. Hinson T.V. Damodaran J. Chen Identification of putative trans-membrane receptor sequences homologous to the calcium-sensing G-protein-coupled receptor Genomics 45 1997 279 289
180. T. Hirano D.B. Burr R.L. Cain Changes in geometry and cortical porosity in dult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1–34) Calcif. Tissue Int. 66 2000 456 460
181. S.R.J. Hoare T.B. Usdin Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors Curr. Pharm. Design. 7 2001 689 713
182. R.J. Hoare T.J. Gardella T.B. Usdin Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor: Effect of receptor G-protein interaction on the ligand binding mechanism and receptor conformation J. Biol. Chem 2000 Online, December 6
183. J.M. Hock Stemming bone loss by suppressing apoptosis J. Clin. Invest. 104 1999 371 373
184. A.B. Hodsman B.M. Steer Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces Bone 14 1993 523 527
185. A.B. Hodsman L.J. Fraher P.H. Watson Parathyroid hormone: The clinical experience and prospects J.F. Whitfield P. Morley Anabolic Treatments for Osteoporosis 1997 CRC Press Boca Raton, FL 83 108
186. A.B. Hodsman L.J. Fraher P.H. Watson A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in post-menopausal women with osteoporsis J. Clin. Endocrinol. Metab. 82 1997 620 628
187. A.B. Hodsman D. Drost L.J. Fraher The addition of raloxifene analog (LY 117018) allows for reduced PTH(1–34) dosing during reversal of osteopenia in ovariectomized rats J. Bone Miner. Res. 14 1999 675 679
188. A.B. Hodsman P.H. Watson D. Drost Assessment of maintenance therapy with reduced doses of PTH(1–34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat Bone 24 1999 451 455
189. A.B. Hodsman P.H. Watson L.J. Fraher Increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical PTH therapy for postmenopausal osteoporosis (abstract) J. Bone Miner. Res. 15 2000 799
190. L.C. Hofbauer S. Khosla C.R. Dunstan Estrogen stimulates gene expression and protein production of osteoprotegerin inhuman osteoblastic cells Endocrinology 140 1999 4367 4370
191. L.C. Hofbauer S. Khoslab C.R. Dunstan The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J. Bone Miner. Res. 15 2000 2 12
192. Y. Honda R. Fitzsimmons D.J. Baylink Effects of extracellular calcium on insulin-like growth factor II in human bone cells J. Bone Miner. Res. 10 1995 1660 1665
193. M.M. Hurley K. Marcello C. Abreu Transcriptional regulation of the collagenase gene by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells Biochem. Biophys. Res. Commun. 214 1995 331 339
194. M.M. Hurley S. Tetradis Y.-F. Huang Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells J. Bone Miner. Res. 14 1999 776 783
195. P. Iacopetti G. Barsacchi F. Tirone Developmental expression of PC3 gene is correlated with neuronal cell birthday Mech. Devel. 47 1994 127 137
196. P. Iacopetti M. Michelini I. Stuckmann Expression of the anti[rpliferative gene TIS21 at the onset of neurogenesis identifies single neuroepithelial cells that switch from proliferative to neuron-generating division Proc. Nod. Acad. Sci. USA 96 1999 4639 4644
197. Y. Ito Molecular basis of tissue-specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF Genes Cells 4 1999 685 696
198. C. Itzstein L. Espinosa P.D. Delmas Specific agonists of NMDA receptors prevent osteoclasts sealing zone formation required for bone resorption Biochem. Biophys. Res. Commun. 268 2000 201 209
199. R. Iwamoto E. Mekada Heparin-binding EGF-like growth factor: A juxtacrine growth factor Cytokine Growth Factor Rev. 11 2000 335 344
200. D.A. Jans G. Hassan Nuclear targeting by growth factors, cytokines, and their receptor: A role in signaling? BioEssays. 29 1998 400 411
201. C.P. Jerome C.S. Carlson T.C. Register Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys ( Macaca fascicularis ) evaluated by serum markers and dynamic histomorphometry J. Bone Miner. Res. 9 1994 527 540
202. C.P. Jerome C.S. Johnson H.T. Vafai Effect of treatment for 6 months with human parathyroid hormone (1–34) peptide in ovariectomized cynomolgus monkeys ( Macaca fascicularis ) Bone 25 1999 301 309
203. C.P. Jerome D.B. Burr T. Van Bibber Treatment with human parathyroid hormone (1–34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys ( Macaca fascicularis ) Bone 28 2001 150 159
204. X. Ji D. Chen C. Xu Patterns of gene expression associated with BMP-2-induced osteoblasts and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A J. Bone Miner. Res. 15 2000 132 139
205. H. Jick G.L. Zornberg S.S. Jick Stains and the risk of dementia Lancet 356 2000 1627 1631
206. R.L. Jilka Cytokines, bone remodeling, and estrogen deficiency Bone 23 1998 75 78
207. R.L. Jilka R.S. Weinstein T. Bellido Increase bone formation by prevention of osteoblast apoptosis with parathyroid hormone J. Clin. Invest. 104 1999 439 446
208. A. Johansson C.J. Rosen The insulin-like growth factors: Potential anabolic agents for the skeleton J.F. Whitfield P. Morley Anabolic Treatments for Osteoporosis 1997 CRC Press Boca Raton, FL 185 205
209. H. Jouishomme J.E. Whitfield B. Chakravarthy The protein kinase-C activation domain of the parathyroid hormone Endocrinology 130 1992 53 60
210. H. Jouishomme J.F. Whitfield L. Gagnon Further definition of the protein kinase C activation domain of the parathyroid hormone J. Bone Miner. Res. 9 1994 943 949
211. D.N. Kalu F.H. Doyle J. Pennock Parathyroid hormone and experimental osteoslerosis Lancet 1 1970 1363 1366
212. T. Kameda H. Mano Y. Yameda Calcium-sensing receptors in mature osteoclasts which are bone-resorbing cells Biochem. Biophys. Res. Commun. 245 1998 419 422
213. M. Kanatami T. Sugimoto Y. Takahashi Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast function J. Bone Miner Res. 13 1998 854 862
214. M. Kanazawa T. Sugimoto M. Kanatami Involvement of osteoprotegerin/ osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells Eur. J. Endocrinol. 142 2000 661 664
215. M. Karperien H. Farih-Sips S.E. Papapoulos Involvement of Cbfa1 in transcritional regulation of the type I PTH/PTHrP-receptor in KS483 osteoblasts (abstract) J. Bone Miner Res. 15 2000 S175
216. G. Karsenty The genetic transformation of bone biology Genes Dev. 13 1999 3037 3051
217. G. Karsenty Role of Cbfal in osteoblast differentiation and function Semin. Cell. Dev. Biol. 11 2000 343 346
218. G. Karsenty The central regulation of bone remodeling Trends Endocrinol. Metab. 11 2000 437 439
219. G. Karsenty Chondrogenesis just ain't what it used to be J. Clin. Invest. 107 2001 405 407
220. V. Kartsogiannis J. Moseley B. McKelvie Temporal expression of PTHrP during endochondral bone formation in mouse and intramembranous bone formation in an in vivo rabbit model Bone 21 1997 385 392
221. A. Kawakami K. Eguchi N. Matsuoka Fas and Fas ligand interaction is necessary for human osteoblast apoptosis J. Bone Miner. Res. 12 1997 1637 1646
222. A. Kawakami T. Nakashima M. Tsuboi Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts Biochem. Biophys. Res. Commun. 247 1998 46 51
223. S.M. Keenan J.J. Baldassare Molecular scaffold protein and cellular responses Trends Endocrinol. Metab. 12 2001 184 186
224. M.J. Kelly E.R. Levin Rapid actions of plasma membrane estrogen receptors Trends Endocrinol. Metab. 12 2001 152 156
225. B. Kern J. Shen M. Starbuck Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes J. Biol. Chem. 2000 Published online December 5
226. H.P. Kim J.Y. Lee J.K. Jeong Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae Biochem. Biophys. Res. Commun. 263 1999 257 262
227. H.W. Kim J.S. Jahng Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats Iowa Orthop J. 19 1999 71 77
228. T. Kinoshita S. Kobayashi S. Ebara Phosphodiesterase inhibitors, pentoxyfylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice Bone 27 2000 811 817
229. R.F. Klein Osteoporosis in men R. Marcus Osteoporosis Atlas of Clincal Endocrinology Vol. 3 1999 Current Medicine Philadelphia 85 99
230. M. Kneissel A. Boyde J.A. Gasser Bone tissue and its mineralization in aged estrogendepleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH-(1–34) Bone 28 2001 237 250
231. K. Kobayashi N. Takahashi E. Jimi Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction J. Exp. Med. 191 2000 275 286
232. T. Komori A fundamental transcription factor for bone and cartilage Biochem. Biophys. Res. Commun. 276 2000 813 816
233. Y.-Y. Kong U. Felge I. Sarosi Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309
234. P.J. Kostenuik V. Shalhoub Osteoprotegerin: A physiological and pharmacological inhibitor of bone resorption Carr Pharm. Design. 7 2001 613 635
235. P.J. Kostenuik J. Harris B.P. Halloran Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I J. Bone Miner. Res. 14 1999 21 31
236. P.J. Kostenuik C. Capparelli S. Morony OPG and PTH-(1–34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats Endocrinology 142 2001 4295 4304
237. V. Krishnan H. Heat H.U. Bryant Mechanism of action of estrogens and selective estrogen receptor modulators Vitamins Hormones 60 2001 123 147
238. M.H. Kroll Parathyroid hormone temporal effects on bone formation and resorption Bull. Math. Biol. 62 2000 163 187
239. R.H. Kufahl S. Saha A theoretical model for stress-generated fluid flow in the canaliculilacunae network in bone tissue J. Biomech. 23 1990 171 180
240. E.H. Kurland F. Cosman D.J. McMahon Parathyroid hormone as a therapy for idiopathic osteoporosis in men: Effects on bone mineral density and bone markers J. Clin. Endocrinol. Metab. 85 2000 3069 3076
241. A.Z. LaCroix J.A. Cauley R. Jackson Does statin use reduce the risk of fracture in postmenopausal women? Results from the Women's Health Initiative Observational Study (WHI-OS) (abstract) J. Bone Miner. Res. 15 2000 S155
242. P. Laharrague D. Larrouy A.M. Fontanilles High expression of leptin by human bone marrow adipocytes in primary culture FASEB J. 12 1998 747 752
243. I. Laketic-Ljubojevic L.J. Suva Functional characterization of the N-methyl-D-aspartic acid-gated channels in bone Bone 25 1999 631 637
244. M.H. Lam C.M. House T. Tiganis Phosphorylation at the cyclin-dependent kinase site (Thr 85) of parathyroid hormone-related protein negatively regulates its nuclear localization J. Biol. Chem. 274 1999 18559 18566
245. M.H.C. Lam R.J. Thomas T.J. Martin Nuclear and nucleolar localization of parathyroid hormone-related protein Immunol. Cell Biol. 78 2000 395 402
246. N.E. Lane J.M. Thompson G.J. Strewler Intermittent treatment with parathyroid hormone (hPTH 1–34) increased trabecular bone volume but not connectivity in osteopenic rats J. Bone Miner. Res. 10 1995 1470 1477
247. N.E. Lane S. Sanchez G.W. Modin Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: Results of a randomized controlled clinical trial J. Bone Miner. Res. 15 2000 944 951
248. M.C. Langub M.-C. Monier-Faugere Q. Qi Parathyroid hormone/parathyroid hormone-related peptide type 1 receptor in human bone J. Bone Miner. Res. 16 2001 448 456
249. B. Lanske M. Amling L. Neff Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development J. Clin. Invest. 104 1999 399 407
250. D. Leaffer M. Sweeny L.A. Kellerman Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1–34), and ovine PTH-(1–34) Endocrinology 136 1995 3624 3631
251. E.R. Levin Nuclear receptor versus plasma membrane oestrogen receptor Novartis Found. Symp. 230 2000 41 55
252. H. Liang S. Pun T.J. Wronski Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats Endocrinology 140 1999 5780 5788
253. J.D. Liang J.M. Hock G.E. Sandusky Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given PTH 1–34 Calcif. Tissue Int. 65 1999 369 373
254. M. Lieberherr B. Grosse M. Kachkache Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional non-nuclear receptors J. Bone Miner. Res. 8 1993 1365 1376
255. S.-Y. Lin K. Makino W. Xia Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat. Cell Biol. 3 2001 802 808
256. R. Lindsay J. Nieves C. Formica Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Lancet 550 1997 555
257. R. Lindsay A. Hodsman H. Genant A randomized controlled multicenter study of 1–84hPTH for treatment of postmenopausal osteoporosis (abstract) Bone 23 1998 S175
258. F. Lorget S. Kamel R. Mentaverri High extracellular calcium concentrations directly stimulate osteoclast apoptosis Biochem. Biophys. Res. Commun. 268 2000 899 903
259. S.S. Lu M. Ducayen-Knowles D.W. Dempster Effects of parathyroid hormone on gene expression of RANK ligand (RANKL), osteoprotegerin (OPG) and the cognate receptor for PTH in mice J. Bone Miner. Res. 16 2001 5426
260. L.M. Luttrell F.L. Roudabush E.W. Choy Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds Proc. Nad. Acad. Sci. USA. 98 2001 2449 2454
261. Y. Ma W. Jee Z. Yuan Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone J. Bone Miner. Res. 14 1999 439 448
262. Y.L. Ma Q.Q. Zeng R.L. Cain PTH induces similar anabolic effects in lumbar vertebrae of adult ovary-intact and osteopenic ovariectomized rats (abstract) J. Bone Miner. Res. 15 2000 813
263. M. Machwate S.B. Rodan G.A. Rodan Sphingosine kinase mediates cyclic AMP suppression of apoptosis in rat periosteal cells Mol. Pharmacol. 54 1998 70 77
264. T. Maeda A. Matsunuma T. Kawane Simvastatin promotes osteoblast differentiation and mineraliuzation in MC3T3 cells Biochem. Biophys. Res. Commun. 280 2001 874 877
265. M.J. Mahon M. Donowitz C.C. Yun Na+/H+ exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signaling Nature 417 2002 858 861
266. H.A. Makhluf S.M. Mueller S. Mizuno Age-related decline in osteoprotegerin expression expression by human bone marrow cells cultured in three-dimensional collagen sponges Biochem. Biophys. Res. Commun. 268 2000 669 672
267. C.A. Mannella Our changing views of mitochondria J. Bioener Biomembr 32 2000 1 4
268. S.C. Manolagas Advances in the treatment of osteoporosis Medscape Endocrinol. J. 1 1999 http://www.medscape.com.
269. S.C. Manolagas Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocrine Rev. 21 2000 115 137
270. S.C. Manolagas R.S. Weinstein T. Bellido Activators of non-genomic estrogen-like signaling (ANGELS): A novel class of small molecules with bone anabolic properties (abstract) J. Bone Miner. Res. 14 1999 S180
271. K. Mansfield C.C. Teixeira C.S. Adams Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism Bone 28 2001 1 8
272. G.A. Maor M. Rochwerger Y. Segev Leptin acts as a skeletal growth factor on chondrocytes of skeletal growth centers J. Bone Miner. Res. 17 2002 1034 1043
273. I. Marenholz M. Zirra D.F. Fischer Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library Genome Res. 11 2001 341 355
274. P.J. Marie D. Jones L. Vico Osteobiology, strain, and microgravity: Part 1. Studies at the cellular level Calcif. Tissue Int. 67 2000 2 9
275. R.B. Martin Toward a unifying theory of bone remodeling Bone 26 2000 1 6
276. R.B. Martin Is all cortical bone remodeling initiated by microdamage? Bone 30 2002 8 13
277. T.J. Martin E. Romas M.T. Gillespie Interleukins in the control of osteoclast differentiation Crit. Rev. Euk. Gene Express. 8 1998 107 123
278. D.J. Mason L.J. Suva P.G. Genever Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents? Bone 20 1997 199 205
279. L.K. McCauley A.J. Koh C.A. Beeches PTH/PTHrP receptor is temporally regulated during osteoblasts differentiation and is associated with collagen synthesis J. Cell. Biochem. 61 1996 638 647
280. M.D. McKee A. Nanci Osteopontin: An interfacial extracellular matrix protein in mineralized tissues Connect. Tissue Res. 35 1996 197 205
281. N. Mehta W. Stern A. Sturmer Oral delivery of PTH analogs by a solid dosage formulation (abstract) J. Bone Miner. Res. 16 2001 S540
282. C.R. Meir R.C. Schlienger M.E. Kraenzlin HMG-CoA reductase inhibitors and the risk of fractures JAMA 283 2000 3205 3210
283. Z. Meleti I.M. Shapiro C.S. Adams Inorganic phosphate induces apoptosis of osteoblastlike cells in culture Bone 27 2000 359 366
284. P.J. Meunier Evidence-based medicine and osteoporosis: A compassion of fracture risk reduction data from osteoporosis randomized clinical trials Int. J. Clin. Pract. 53 1999 122 129
285. W.E. Miller P.H. McDonald S.F. Cai Identification of a motif in the carboxyl terminus of β-arrestin 2 responsible for activation of JNK3 J. Biol. Chem. 276 2001 27770 27777
286. M.H. Moghadasian J.J. Frohlich Statins and bones Can. Med. Assoc. J. 164 2001 803 805
287. S. Mohan D.J. Baylink IGF system components and their role in bone metabolism R.G. Rosenfeld C.T. Roberts Jr. The IGF System. Molecular Biology, Physiology, and Clincal Applications 1999 Humana Press Totowa, NJ 457 496
288. S. Mohan S. Kutilek C. Zhang Comparison of bone formation responses to parathyroid hormone(1–34), (1–31), and 2–34 in mice Bone 27 2000 471 478
289. A. Montero Y. Okada M. Tomita Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation J. Clin. Invest. 105 2000 1085 1093
290. B.S. Moonga D.W. Dempster Effects of peptide fragments of protein kinase C on isolated rat osteoclasts Exp. Physiol. 83 1998 717 725
291. 2+ sensing (abstract) J. Bone Miner. Res. 14 1998 S363
292. T.L. Moore V.G. Krishnan J.E. Onyia A mechanism for bone anabolic activity of PTH through Cbfal/Osf-2 (abstract) J. Bone Miner. Res. 15 2000 S158
293. P. Morley J.F. Whitfield G. Willick Design and application of parathyroid hormone analogues Curr. Med. Chem. 11 1999 1095 1106
294. 2 on bone formation and mechanical strength in ovariectomized rats Calcif Tissue. Int. 68 2001 95 101
295. L. Mosekilde Osteoporosis: Mechanisms and models J.F. Whitfield P. Morley Anabolic Treatments for Osteoporosis 1997 CRC Press Boca Raton, FL 31 58
296. L. Mosekilde J.S. Thomsen J.E. McOsker No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model Bone 20 1997 429 437
297. G. Mundy Pathogenesis of osteoporosis and challenges for drug delivery Adv. Drug Del. Res. 42 2000 165 173
298. G. Mundy R. Garrett S. Harris Stimulation of bone formation in vitro and in rodents by statins Science 286 1999 1946 1949
299. E.J.B. Murray S.S. Murray Lovastatin stimulates rather than inhibits proteasome in vitro and in osteoblasts (abstract) J. Bone Miner. Res. 16 2001 S206
300. A. Nadal J.M. Rovira O. Laribi Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor FASEB J. 12 1998 1341 1348
301. A. Nadal A.B. Ropero O. Laribi Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane recepor unrelated to estrogen receptor a and estrogen receptor β Proc. Natl. Acad. Sci. USA 97 2000 11603 11608
302. O. Nakade K. Takahashi T. Takuma Effect of extracellular calcium on the gene expression of bone morphogenic protein-2 and -4 of normal human bone cells J. Bone Miner. Metab. 19 2001 13 19
303. M. Nakajima S. Ejiri M. Tanaka Effects of intermittent administration of human parathyroid hormone (1–34) on mandibular condyle of ovariectomized rats J. Bone Miner. Metab. 18 2000 9 17
304. K. Nakamura J. Nishimura K. Hirano Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase J. Cereb. Blood Flow Metab. 21 2001 876 885
305. K. Nakashima X. Zhou G. Kunkel The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation Cell 108 2002 17 29
306. R. Neer D. Slovik M. Daly Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol C. Christiansen K. Overgaard Osteoporosis 1991 Osteopress Copenhagen 1314 1317
307. R.M. Neer C.D. Arnaud J.R. Zanchetta Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis N. Engl. J. Med. 344 2001 1434 1441
308. C. Netelenbos Osteoporosis: Intervention options Maturitas 30 1998 235 239
309. W. Neugebauer J.-R. Barbier W.L. Sung Solution structure and adenylyl cyclase stimulating activities of C-terminal truncated human parathyroid hormone analogues Biochemistry 34 1995 8835 8842
310. C.-Y. Ni M.P. Murphy T.E. Golde γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase Science 294 2002 2179 2181
311. L.B. Nielsen F.S. Pedersen L. Pedersen Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation Bone 28 2001 160 166
312. S. Nishida A. Yamaguchi T. Tanizawa Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow Bone 15 1994 717 723
313. S. Nishida N. Endo H. Yamagiwa Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation J. Bone Miner. Metab. 17 1999 171 177
314. B.S. Noble Osteocyte death: Its biological significance (abstract) J. Bone Miner. Res. 15 2000 823
315. B.S. Noble J. Reeve Osteocyte function, osteocyte death and bone fracture resistance Mol. Cell. Endocrinol. 159 2000 7 13
316. M. Noda Y. Takuwa T. Katoh Mechanical force regulation of vascular parathyroid hormone-related peptide expression Kidney Int. Suppl. 55 1996 S154 S1555
317. S. Nomura T. Takano-Yamamoto Molecular events caused by mechanical stress in bone Matrix Biol. 19 2000 91 96
318. C.A. O'Brien B. Kern I. Gubrij Analysis of the role of Cbfal in RANKL expression J. Bone Miner. Res. 15 2000 S270
319. M. Okada-Ban J.P. Thiery J. Jouanneau Fibroblast growth factor-2 Int. J. Biochem. Cell Biol. 32 2000 263 267
320. K. Ohnaka S. Shimoda H. Nawata Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of rho-associated kinase in human osteoblasts Biochem. Biophys. Res. Commun. 287 2001 337 342
321. J.E. Oniya R.R. Miles D.L. Halladay In vivo demonstration that parathyroid hormone (hPTH 1–38) inhibits the expression of osteoprotegerin (OPG) in bone with the kinetics of an immediate early gene J. Bone Miner. Res. 15 2000 863 871
322. J.E. Onyia I. Gelbert M. Zhang Analysis of gene expression by DNA microarray reveals novel clues to the mechanism of the catabolic and anabolic actions of PTH in bone (abstract) J. Bone Miner. Res. 16 2001 S227
323. J.E. Onyia Y.L. Ma E. Galbreath ADAMTS-1: A cellular disinetgrin and metalloprotease with thrombospondin motifs is essential for normal bone growth and PTH regulated bone metabolism (abstract) J. Bone Miner. Res. 16 2001 S158
324. 2 preferentially increase luciferase levels in bone of mice harboring a luciferase transgene controlled by the elements of the pro-α (I) collagen promoter Bone 27 2000 27 32
325. D.M. Ornitz N. Itoh Fibroblast growth factors Genome Biol. 2 2001 http://genomebiology.com/2001 /2/3/reviews/3995.1.
326. S. Ott Osteoporosis http://courses.washington.edu/bonephys/
327. B.O. Oyajobi D.M. Anderson K. Traianedes Therapeutic efficacy of a soluble receptor activator of nuclear factor κB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of Immoral hypercalcemia of malignancy Cancer Res. 61 2001 2572 2578
328. P.K. Panegyres The functions of the amyloid precursor gene Rev. Neurosci. 12 2001 1 39
329. A.M. Parfitt Osteoclast precursors as leukocytes: Importance of the area code Bone 23 1998 491 494
330. A.M. Parfitt BMU origination and progression: Relationship to targeted and nontargeted remodeling (abstract) J. Bone Miner. Res. 15 2000 823
331. A.M. Parfitt The mechanism of coupling: A role for the vasculature Bone 26 2000 319 323
332. A.M. Parfitt The bone remodeling compartment: acirculatory function for bone lining cells J. Bone Miner. Res. 16 2001 1583 1585
333. A.J. Patton P.G. Genever M.A. Birch Expression of an N-methyl-D-aspartate receptor by human and rat osteoblasts and osteoblasts suggests a novel glutamate signaling pathway in bone Bone 22 1998 645 649
334. L. Pavo F. Laszlo E. Morschl J. Newmesik Raloxifene, an estrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats Eur. J. Pharmacol. 410 2000 101 104
335. N.M. Peet P.S. Grabowski L. Laketic-Ljubojevic The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation FASEB J 13 1999 2179 2185
336. M. Péhu A. Policard A. Dufort L'Ostéopetrose ou maladie des os marmoréens La Presse Med. 53 1931 999 1003
337. A.D. Perris J.P. MacManus J.F. Whitfield Parathyroid glands and mitotic stimulation in rat bone marrow after hemorrhage Am. J. Physiol. 220 1971 773 778
338. J. Pfeilschrifter F. Laukhuf B. Mηlller-Beckmann Parathyroid hormone increases the concentration of insulin-like growth factor-1 and transforming growth factor beta 1 in rat bone J. Clin. Invest. 96 1995 767 774
339. M. Pi T.K. Hinson L.D. Quarles Failure to detect the extracellular calcium-sensing receptor (CasR) in human osteoblast cell lines J. Bone Miner. Res. 14 1999 1310 1319
340. M. Pi S.C. Garner P. Flannery Sensing of extracellular cations in CasR-deficient osteoblasts. Evidence for a novel cation-sensing mechanism J. Biol. Chem. 275 2000 3256 3263
341. + influx Biochem. J. 339 1999 71 77
342. C. Pilbeam Y. Rao C. Alander Downregulation of mRNA expression for the ‘decoy’ interleukin-1 receptor 2 by ovariectomy (abstract) J. Bone Miner. Res. 12 Suppl. 1 1997 S433
343. C.J. Pirola H.M. Wang M.I. Strgacich Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro Endocrinology 134 1994 2230 2236
344. J. Pouysségur Signal transduction: An arresting start for MAPK Science 290 2000 1574 1577
345. N. Prenzel E. Zwick H. Daub EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of pro-HB-EGF Nature 402 1999 884 888
346. S. Pugazhenthi E. Miller C. Sable Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein J. Biol. Chem. 274 1999 27529 27535
347. A. Raouf A. Seth Discovery of osteoblast-associated genes using cDNA microarrays Bone 30 2002 463 471
348. M. Razandi A. Pedram G.L. Greene Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells Mol. Endocrinol 13 1999 307 319
349. R.N. Re Toward a theory of intracrine hormone action Regul. Pept. 106 2002 1 6
350. J. Reeve R. Hesp D. Williams Anabolic effect of low doses of a fragment of human parathyroid hormone fragment on the skeleton in postmenopausal osteoporosis Lancet. I 1976 1035 1036
351. J. Reeve G.W. Tregear J.A. Parsons Preliminary trial of low doses of human parathyroid hormone fragment 1–34 in treatment of osteoporosis Clin. Endocrinol. 21 1976 469 477
352. J. Reeve P.J. Meunier J.A. Parsons Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutibnal osteoporosis: A multicentre trial Br. Med. J. 280 1980 1340 1344
353. J. Reeve A. Mitchell M. Tellez Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis; prediction of long-term responses in spine and femur J. Bone Miner. Metab. 19 2001 102 114
354. I.R. Reid W. Hague J. Emberson Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomized controlled trial. Long-term intervention with pravastatin in ischaemic disease Lancet 357 2001 509 512
355. J.E. Reseland J.O. Gordeladze C.A. Drevon Leptin receptor (OB-R) gene expression in human primary osteoblasts:reaffirmation J. Bone Miner. Res. 17 2002 1136
356. J. Reseland U. Syversen L. Bakke Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization J. Bone Miner. Res. 16 2001 1426 1433
357. A.A. Reszka J.M. Halasy-Nagy P.J. Masarachia Bisphosphoinates act directly on the osteoclast to induce caspase cleavage of Mstl kinase during apoptosis J. Biol. Chem. 274 1999 34967 34973
358. B.L. Riggs The mechanism of estrogen regulation of bone resorption J. Clin. Invest. 106 2000 1203 1204
359. R.S. Rittmaster M. Bolognese M.P. Ettinger Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate J. Clin. Endocrinol. Metab. 85 2000 2129 2134
360. R.H. Rixon J.F. Whitfield L. Gagnon Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase J. Bone Miner. Res. 9 1994 1179 1189
361. E.B. Roe K.M. Chin C.D. Arnaud Selective estrogen receptor modulators and postmenopausal health Adv. Intern. Med. 45 2000 259 278
362. G.D. Roodman Advances in bone biology: The osteoclast Endocrine Rev. 17 1996 308 332
363. E.B. Rose S.D. Sanchez G.A. Del Puerto Parathyroid hormone 1–34 (hPTH I-34) and estrogen produce dramatic bone density increases in postmenopausal osteoporosis (abstract) J. Bone Miner. Res. 14 1999 S137
364. C.J. Rosen J.P. Bilezikian Anabolic therapy for osteoporosis J. Clin. Endocrinol. Metab. 86 2001 957 964
365. J. Roufflet V. Coxam N. Gaumet Preserved bone mass in ovarectomized rats treated with parathyroid-hormone-related peptide (1–34) and (107–111) fragments Reprod. Nutr Dev. 34 1994 473 481
366. E. Ruoslahti D. Rajotte The address system in the vasculature of normal tissues and tumors Annu. Rev. Immunol. 18 2000 813 827
367. 2+ channels J. Bone Miner. Res. 16 2001 240 248
368. H.M. Ryon H.M. Hoffmann T. Beumer Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression Mol. Endocrinol. 11 1997 1681 1694
369. H. Sakai Y. Kobayashi E. Sakai Cell adhesion is a prerequisite for osteoclast survival Biochem. Biophys. Res. Commun. 270 2000 550 556
370. E. Samnegard U.T. Iwaniec D.M. Cullen Maintenance of cortical bone in human parathyroid hormone(1–84)-treated ovariectomized rats Bone 28 2001 251 260
371. M. Sato A. Schmidt H. Cole The skeletal efficacy of statins do not compare with low-dose parathyroid hormone (abstract) Bone 28 2001 S80
372. M.B. Schaffler The role of osteocytes in targeting microdamage-induced remodeling (abstract) J. Bone Miner. Res. 15 2000 823
373. P.C. Schiller G. D'Ippolito B.A. Roos Anabolic or catabolic responses of MC3T3-E 1 osteoblastic cells to parathyroid hormone depends on time and duration of treatment J. Bone Miner. Res. 14 1999 1504 1512
374. B. Schwartz P. Smirnoff S. Shany Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon Mol. Cell. Biochem. 203 2000 87 93
375. H.R. Schweitert E.W.J. Groen E.A.E. Sollie Single dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1–84)] in healthy postmenopausal volunteers Clin. Pharmacol. Ther 61 1997 360 376
376. E. Seeman How do antiresorptive agents reduce fracture? 2001 IBMS BoneKEy 2001 January 23 10.1138/ibmske; 20011012
377. N. Selvamurugan M.R. Pulumati D.R. Tyson Parathyroid hormone regulation of the rat collagenase-3 promoter by protein linase A-dependent transactivation of core binding factor a I J. Biol. Chem. 275 2000 5037 5042
378. H. Selye On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol Endocrinology 16 1932 547 558
379. T. Selz J. Caverzasio J.-P. Bonjour Regulation of Na-dependent P; transport by parathyroid hormone in osteoclast-like cells Am. J. Physiol. 256 1989 E93 E100
380. C.M. Serre D. Farlay P.D. Delmas Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers Bone 25 1999 623 629
381. J. Shepherd Lipid lowering: Statins and the future Heart 84 2000 46 47
382. H. Shimokawa M. Seto N. Katsumata Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylation in a swine model of coronary artery spasm Cardiovasc. Res. 43 1999 1029 1039
383. K. Shirakabe K. Terasawa K. Miyama Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5 Genes Cells 6 2001 851 856
384. A.T. Singh J.G. Kunnel P.J. Strieleman Parathyroid hormone (PTH)-(1–34), [Nle(8,18),Tyr34]PTH-(3–34) amide, PTH-(1–31)amide, and PTH-related peptide-(1–34) stimulate phosphatidylcholine hydrolysis in UMR-106 osteoblastic cells: Comparison with effects of phorbol 12,13-dibutyrate Endocrinology 140 1999 131 137
385. J. Sirola R. Honkanen H. Kröger Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women Osteoporosis Int. 13 2002 537 541
386. T.M. Skerry Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: The role of glutamate as a paracrine signaling agent in the skeleton J. Bone Miner. Metab. 17 1999 66 70
387. T.M. Skerry P.G. Genever Glutamate signaling in non-neuronal tissues Trends Pharmacol. Sci. 22 2001 174 181
388. L. Soerensen E.F. Eriksen Endothelial cells mediate osteoblastic responses to sex steroids and selective estrogen receptor modulators (SERMS) via NO independent pathways (abstract) Bone 23 1998 S369
389. C.H. Sogaard L. Mosekilde J.S. Thomsen A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model Bone 20 1997 439 449
390. D.H. Solomon J.S. Finkelstein E.S. Wang Statin lipid-lowering drugs and bone density (abstract) J. Bone Miner. Res. 16 2001 S293
391. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm Cell 76 1994 301 314
392. W.D. Steers S.R. Broder K. Persson Mechanical stretch increases secretion of parathyroid hormone-related protein by cultured bladder smooth muscle cells J. Urol. 160 1998 908 912
393. G.B. Stefano D. Peter Cell surface estrogen receptors coupled to eNOS mediate immune and vascular tissue regulation: Therapeutic implications Med. Sci. Monit. 7 2001 1066 1074
394. C.M. Steppan D.T. Crawford K.L. Chidsey-Frink Leptin is a potent stimulator of bone growth in ob/ob mice Regul. Peptides 92 2000 73 78
395. J.C. Stevenson R. Lindsay Osteoporosis 1999 Chapman & Hall Medical London Current Medicine, Philadelphia
396. L.S. Stilgren S. Reppe B. Abrahamsen Differential effects of PTH peptides on OPG and RANK-L mRNA expression in human OHS osteosarcoma cells: A possible pathway of osteoblast dependent bone resorption (abstract) J. Bone Miner. Res. 16 2001 S545
397. K. Strein Are animal studies with bisphosphonates and PTH fragments predictive for the clinical studies? R.G. Russell Bone Diseases and Osteoporosis 1994 IBC Technical Services Limited London article 12
398. T. Suda N. Takahashi N. Udagawa Modulation of osteoblast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocrine Rev. 20 1999 345 357
399. T. Sugimoto M. Kanatani J. Kano IGF-I mediates the stimulatory effect of high calcium concentration on osteoblastic cell proliferation Am. J. Physiol. 266 1994 E709 E716
400. M. Sugiyama T. Kodama K. Konishi Compactin and simvastatiin, but not pravastatin, induce bone morphogenic protein-2 in human osteosarcoma cells Biochem. Biophys. Res. Commun. 271 2000 688 692
401. W.L. Sung B.S. Chan C.K. Luk High-yield expression of fully bioactive N-terminal parathyroid hormone analogue in Escherichia coli IUBMB Life. 49 2000 131 135
402. T. Sunyer J. Lewis P. Collin-Osdoby Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells J. Clin. Invest. 103 1999 1409 1418
403. J.T. Swarth T.A. Doggett J.L. Lemken Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C dependent J. Biol. Chem. 2000 Published online December 6
404. H. Takai M. Kanematsu K. Yano Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells J. Biol. Chem. 273 1998 27091 27096
405. E. Takeda Y. Taketani K. Morita Sodium-dependent phosphate cotransporters Int. J. Biochem. Cell Biol. 31 1999 377 381
406. C.S. Tam J.N. Heersche T.M. Murray Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration Endocrinology 110 1982 506 512
407. T. Tamura N. Udgawa N. Takahashi Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6 Proc. Natl. Acad. Sci. USA 90 1993 11924 11928
408. E. Tan M.V. Gurjar R.V. Sharma Estrogen receptor-α transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration Cardiovasc. Res. 43 1999 788 797
409. A.F. Taylor A.C. Brabbs N.M. Peet Bone formation/resorption and osteoblast/adipocytes plasticity mediated by AMPA/kainate glutamate receptors in vitro and in vivo (abstract) J. Bone Miner Res. 15 2000 S275
410. K. Thirunavukkamasu D.L. Halladay The osteoblast-specific transcription factor Cbfa I contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function J. Biol. Chem. 275 2000 25163 25172
411. T. Thomas E. Gori S. Khosla Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes Endocrinology 140 1999 630 1638
412. D. Thomas S.A. Cart D.M. Piscopo The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation Mol. Cell 8 2001 303 316
413. T. Thomas R. De Vittoris V.N. David Leptin prevents disuse-induced bone loss in tail-suspended female rats (abstract) J. Bone Miner. Res. 16 2001 S143
414. Y. Tintut F. Parhami V. Le Inhibition of osteoblast-specific transcription factor Cbfa I by the cAMP pathway in otseoblastic cells. Ubiquitin/proteasome-dependent regulation J. Biol. Chem. 274 1999 28875 28879
415. A. Tomkinson E.F. Gevers J.M. Wit The role of estrogen in the control of osteocyte apoptosis J. Bone Miner. Res. 13 1998 12143 12150
416. C.D. Toran-Allerand Novel sites and mechanisms of oestrogen action in the brain Novartis Found. Symp. 230 2000 56 69
417. A. Toromanoff P. Ammann L. Mosekilde Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats Endocrinology 138 1997 2449 2457
418. V.A. Tovar-Sepulveda X. Shen M. Falzon Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells Endocrinology 143 2002 596 606
419. A. Tumber M.C. Meikle P.A. Hill Autocrine signals promote osteoblast survival in culture J. Endocrinol. 167 2000 383 390
420. E. Van Beek E. Pieterman L. Cohen Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates Biochem. Biophys. Res. Commun. 264 1999 108 111
421. D. Vanderschueren S. Boonen G.H. Ederveen Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged rat model Bone 27 2000 611 617
422. T.P. Van Staa S.L.J. Wegman F. DeVries The use of statins and risk of fractures (abstract) J. Bone Miner. Res. 15 2000 S155
423. R.J. van't Hof S.H. Ralston Nitric oxide and bone Immunology 103 2001 255 261
424. L. Vico M. Hinsenkamp D. Jones Osteobiology, strain, and microgravity. Part 11: Studies at the tissue level Calcif. Tissue Int. 68 2001 1 10
425. J.-P. Vilardaga C. Krasel S. Chauvin Internalization determinants of the parathyroid hormone receptor differentially regulate β-arrestiin/receptor association J. Biol. Chem. 277 2002 8121 8129
426. K. Virdee P.A. Parone A.M. Tolkovsky Phosphorylation of the proapoptosis protein BAD on serine 155, a novel site, contributes to cell survival Curr Biol. 10 2000 1151 1154
427. D. Walker The induction of osteopetrotic changes in hyphophysectomized, thyroparathyroidectomized, and intact rats of various ages Endocrinology 89 1971 1389 1406
428. C.A. Walsh W.B. Bowler G. Bilbe Effects of PTH on PIMP gene expression in human osteobasss: Upregulation with the kinetics of an immediate early gene Biochem. Biophys. Res. Commun. 239 1997 155 159
429. P.S. Wang D.H. Solomon H. Mogun HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients JAMA 283 2000 3211 3216
430. P. Watson D. Lazowski V. Han Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats Bone 16 1995 365 375
431. P.H. Watson L.J. Fraher M. Kisiel Enhanced osteoblast development after continuous infusion of hPTH-(1–84) in the rat Bone 24 1999 89 94
432. P.H. Watson L.J. Fraher G.N. Hendy Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues J. Bone Miner. Res. 15 2000 1033 1044
433. P.H. Watson L.J. Fraher B.V. Natale Nuclear localization of the type 1 parathyroid/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: Association with seruminduced cell proliferation Bone 26 2000 221 225
434. R.S. Weinstein R.L. Jilka M. Parfitt Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoid J. Clin. Invest. 102 1998 274 282
435. K. Whang M. Zhao M. Qiao Administration of lovastatin locally in low doses in a novel delivery system induces prolonged bone formation (abstract) J. Bone Miner. Res. 15 2000 S225
436. J.F. Whitfield Statins; new drugs for treating osteoporosis? Exp. Opin. Invest. Drugs 10 2001 409 415
437. J.E. Whitfield Leptin, brains and bones Exp. Opin. Invest. Drugs 10 2001 1617 1622
438. J.F. Whitfield T. Youdale A.D. Perris Early postirradiation changes leading to the loss of nuclear structure in rat thymocytes Exp. Cell Res. 48 1967 461 472
439. J.F. Whitfield P. Morley V. Ross Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1–34) Calcif. Tissue Int. 56 1995 227 231
440. J.F. Whitfield R.J. Isaacs H. Jouishomme C-terminal fragment of parathyroid hormone-related protein, PTHrP-(107–111), stimulates membrane-associated protein kinase C activity and modulates the proliferation of human and murine skin keratinocytes J. Cell. Physiol. 166 1996 1 11
441. 2 (ostabolin) Calcif. Tissue Int. 58 1996 81 87
442. J.F. Whitfield P. Morley V. Ross The hypotensive actions of opsteogenic and nonosteogenic parathyroid hormone fragments Calcif. Tissue Int. 60 1997 302 308
443. 2 to stimulate bone growth in ovariectomized rats J. Bone Miner Res. 12 1997 1246 1252
444. 2 to stimulate femoral trabecular bone growth on ovariectomized rats Calcif. Tissue Int. 60 1997 26 29
445. 2 to stimulate femoral trabecular bone growth in ovariectomized rats Calcif. Tissue Int. 61 1997 322 326
446. J.E. Whitfield P. Morley G.E. Willick The Parathyroid Hormone: An Unexpected Bone Builder for Treating Osteoporosis 1998 Landes Bioscience Company Austin
447. 2 to stimulate femoral trabecular bone growth in ovariectomized rats Calcif. Tissue Int. 63 1998 423 428
448. 2 Cell. Signal. 11 1999 159 164
449. J.F. Whitfield P. Morley G. Willick The bone-building actions of the parathyroid hormone: Implications for the treatment of osteoporosis Drugs Aging. 15 1999 117 129
450. 2 Calcif. Tissue Int. 65 1999 143 147
451. 2 Calcif. Tissue Int. 66 2000 307 312
452. J.F. Whifield P. Morley G.E. Willick The parathyroid hormones: Bone-forming agents for treatment of osteoporosis Medscape Women's Health 5 2000 http://womenshealth.medscape.com.
453. 2 J. Bone Miner. Res. 15 2000 964 970
454. J.F. Whitfield P. Morley G. Willick The parathyroid hormone, its fragments and analogs-potent bone-builders for treating osteoporosis Exp. Opin. Invest. Drugs 9 2000 1293 1315
455. J.F. Whitfield R.J. Isaacs B. Chakravarthy Stimulation of protein kinase-C activity in cells expressing human parathyroid hormone (PTH) receptors by C- and N-terminally truncated fragments of PTH-(1–34) J. Bone Miner. Res. 16 2001 441 447
456. J.F. Whifield P. Morley G. Willick The control of bone growth by parathyroid hormone (PTH), leotin and statins Crit. Rev. Euk. Gene Express 12 2002 23 51
457. J.F. Whitfield B. Chakravarthy Calcium: the Grand-Master Cell Signaler 2002 NRC Research Press Ottawa
458. B. Wolozin W. Kellman P. Ruosseau Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors Arch. Neurol. 57 2000 1439 1443
459. T.J. Wronski M. Li PTH: Skeletal effects in the ovariectomized rat model for Osteoporosis J.F. Whitfield P. Morley Anabolic Treatments for Osteoporosis 1997 CRC Press Boca Raton. FL 59 81
460. Y. Wu R. Kumar Parathyroid hormone regulates transforming growth factor β1 and β2, synthesis in osteoblasts via divergent signaling pathways J. Bone Miner. Res. 15 2000 879 884
461. H.L. Xu E. Galea R.A. Santizo The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide function in cerebral arterioles in vivo J. Cereb. Blood Flow Metab. 21 2001 907 913
462. A. Yamaguchi T. Komori T. Suda Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehog and Cbfa 1 Endocrinology 21 2000 393 411
463. 2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-El cells J. Bone Miner Res. 13 1998 1530 1538
464. 2+o)-sensing receptor in the clonal osteoblast-like cellines, UMP-106 and SAOS-2 Biochem. Biophys. Res. Commun. 243 1998 753 757
465. T. Yamaguchi N. Chattopadhyay O. Kifor Activation of p42/44 and p38 mitogenactivated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line Biochem. Biophys. Res. Commun. 279 2000 363 368
466. T. Yamaguchi N. Chattopadhyay O. Kifor Expression of extracellular calcium-sensing receptors in human osteoblastic MG-63 cell line Am. J. Physiol. Cell. Physiol. 280 2001 C382 0393
467. T. Yamashiro T. Fukunaga K. Yamashita Gene and protein expression of brain-derived neurotrophic factor and TrkB in bone and cartilage Bone 28 2001 404 409
468. W. Yao C.Y. Li R.W. Farmer Simvastatin did not prevent bone loss in ovariectomized rat (abstract) J. Bone Miner. Res. 16 2001 S294
469. C.E. Yellowley L.I. Zhongyong Z. Zhou Functional gap junctins between osteocytic and osteoblastic cells J. Bone Miner. Res. 15 2000 209 217
470. A. Zaid O.A. Adebanjo B.S. Moonga Emerging insights into the role of calcium ions in osteoclast regulation J. Bone Miner. Res. 14 1999 669 674
471. S. Zecchi-Orlandini L. Formigh A. Tani 17β-estradiol induces apoptosis in the preosteoclastic FLG29.1 cell line Biochem. Biophys. Res. Commun. 255 1999 680 685
472. M.H. Zheng H.B. McCaughan J.M. Papadimitriou Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein J. Cell. Biochem. 54 1994 145 153
473. R.W. Zhang S.C. Supowit X. Xu Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma Calcif Tissue Int. 56 1995 283 291
474. Y.-X. Zhou X. Xu L. Chen A Pro250Arg substitution in mouse Fgfr 1 causes increased expression of Cbfal and premature fusion of calvarial sutures Hum. Mol. Genet. 9 2000 2001 2008